Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2025 Filed Feb 20, 2025 22:30 UTC |
Sims Andrew John Hugh MacIntyreChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 60,020 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0000950170-25-024337 · ownership.xml · derivative · entry 1 Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,020 Underlying: Common Stock · 60,020 shares Expires 2035-02-17 F1 · derivative.exercise_date: (1) The option vest over four years in equal 1/48th increments on each monthly anniversary of the issuance. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:30 UTC |
van Es-Johansson AnDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,122 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0000950170-25-024341 · ownership.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,122 Underlying: Common Stock · 40,122 shares Expires 2035-02-17 F1 · derivative.exercise_date: 1. The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:30 UTC |
HEDRICK MARC HDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 400,489 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0000950170-25-024340 · ownership.xml · derivative · entry 1 HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,489 Underlying: Common Stock · 400,489 shares Expires 2035-02-17 F1 · derivative.exercise_date: (1) The option vest over four years in equal 1/48th increments on each monthly anniversary of the issuance. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:30 UTC |
Petersen GregDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,122 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0000950170-25-024339 · ownership.xml · derivative · entry 1 Petersen Greg · CIK 0001406815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,122 Underlying: Common Stock · 40,122 shares Expires 2035-02-17 F1 · derivative.exercise_date: 1. The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 11:00 UTC |
Hawkins Richard JDirector
|
PurchaseCommon Stock | 4,000 | $1.50 | $5,996.00 |
DisclosureSEC source: 0000950170-24-107008 · ownership.xml · nonDerivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,188 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.47 to $1.50 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 11:00 UTC |
Hawkins Richard JDirector
|
PurchaseCommon Stock | 6,285 | $1.35 | $8,511.78 |
DisclosureSEC source: 0000950170-24-106605 · ownership.xml · nonDerivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,188 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.27 or $1.40 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 20:30 UTC |
Lenk Robert PDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,650 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0000950170-24-105961 · ownership.xml · derivative · entry 1 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2034-09-11 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 20:30 UTC |
van Es-Johansson AnDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,650 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0000950170-24-105960 · ownership.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2034-09-11 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 20:30 UTC |
Hawkins Richard JDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,650 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0000950170-24-105959 · ownership.xml · derivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2034-09-11 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 20:30 UTC |
Clowes HowardDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,650 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0000950170-24-105958 · ownership.xml · derivative · entry 1 Clowes Howard · CIK 0001806992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2034-09-11 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 20:30 UTC |
Petersen GregDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,650 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0000950170-24-105957 · ownership.xml · derivative · entry 1 Petersen Greg · CIK 0001406815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2034-09-11 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 20:30 UTC |
Sims Andrew John Hugh MacIntyreChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 46,074 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0000950170-24-105956 · ownership.xml · derivative · entry 1 Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,074 Underlying: Common Stock · 46,074 shares Expires 2034-09-11 F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement. Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 20:30 UTC |
HEDRICK MARC HDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 197,595 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0000950170-24-105954 · ownership.xml · derivative · entry 1 HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,595 Underlying: Common Stock · 197,595 shares Expires 2034-09-11 F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 10:04 UTC |
Petersen GregDirector
|
PurchaseCommon Stock | 12,500 | $1.35 | $16,875.00 |
DisclosureSEC source: 0000950170-24-106180 · ownership.xml · nonDerivative · entry 1 Petersen Greg · CIK 0001406815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,921 Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 10:04 UTC |
Clowes HowardDirector
|
PurchaseCommon Stock | 5,000 | $1.34 | $6,681.00 |
DisclosureSEC source: 0000950170-24-106179 · ownership.xml · nonDerivative · entry 1 Clowes Howard · CIK 0001806992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,497 Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 10:02 UTC |
HEDRICK MARC HDirector · Chief Executive Officer
|
PurchaseCommon Stock | 8,000 | $1.23 | $9,839.20 |
DisclosureSEC source: 0000950170-24-105331 · ownership.xml · nonDerivative · entry 1 HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,425 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.22 or $1.23 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 10:02 UTC |
Sims Andrew John Hugh MacIntyreChief Financial Officer
|
PurchaseCommon Stock | 4,098 | $1.27 | $5,204.46 |
DisclosureSEC source: 0000950170-24-105330 · ownership.xml · nonDerivative · entry 1 Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,815 Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
Sims Andrew John Hugh MacIntyreChief Financial Officer
|
GrantWarrants (Right to buy) · Derivative | 9,804 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0000950170-24-057456 · ownership.xml · derivative · entry 2 Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,804 Underlying: Common Stock Warrants · 9,804 shares Expires not disclosed F1 · derivative.expiration_date: The expiration date for 4,902 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,902 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants. F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants. Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
Sims Andrew John Hugh MacIntyreChief Financial Officer
|
PurchaseCommon Stock | 4,902 | $2.04 | $10,000.08 |
DisclosureSEC source: 0000950170-24-057456 · ownership.xml · nonDerivative · entry 1 Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,717 Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
HEDRICK MARC HDirector · Chief Executive Officer
|
GrantWarrants (Right to buy) · Derivative | 24,510 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0000950170-24-057455 · ownership.xml · derivative · entry 2 HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,510 Underlying: Common Stock Warrants · 24,510 shares Expires not disclosed F1 · derivative.expiration_date: The expiration date for 12,255 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 12,255 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants. F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants. Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
HEDRICK MARC HDirector · Chief Executive Officer
|
PurchaseCommon Stock | 12,255 | $2.04 | $25,000.20 |
DisclosureSEC source: 0000950170-24-057455 · ownership.xml · nonDerivative · entry 1 HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,425 Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
Petersen GregDirector
|
GrantWarrants (Right to buy) · Derivative | 24,510 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0000950170-24-057454 · ownership.xml · derivative · entry 2 Petersen Greg · CIK 0001406815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,510 Underlying: Common Stock Warrants · 24,510 shares Expires not disclosed F1 · derivative.expiration_date: The expiration date for 12,255 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 12,255 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants. F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants. Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
Petersen GregDirector
|
PurchaseCommon Stock | 12,255 | $2.04 | $25,000.20 |
DisclosureSEC source: 0000950170-24-057454 · ownership.xml · nonDerivative · entry 1 Petersen Greg · CIK 0001406815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,421 Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
Clowes HowardDirector
|
GrantWarrants (Right to buy) · Derivative | 19,608 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0000950170-24-057452 · ownership.xml · derivative · entry 2 Clowes Howard · CIK 0001806992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,608 Underlying: Common Stock Warrants · 19,608 shares Expires not disclosed F1 · derivative.expiration_date: The expiration date for 9,804 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 9,804 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants. F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants. Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
Clowes HowardDirector
|
PurchaseCommon Stock | 9,804 | $2.04 | $20,000.16 |
DisclosureSEC source: 0000950170-24-057452 · ownership.xml · nonDerivative · entry 1 Clowes Howard · CIK 0001806992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,497 Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
Hawkins Richard JDirector
|
GrantWarrants (Right to buy) · Derivative | 9,804 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0000950170-24-057453 · ownership.xml · derivative · entry 2 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,804 Underlying: Common Stock Warrants · 9,804 shares Expires not disclosed F1 · derivative.expiration_date: The expiration date for 4,902 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,902 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants. F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants. Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
Hawkins Richard JDirector
|
PurchaseCommon Stock | 4,902 | $2.04 | $10,000.08 |
DisclosureSEC source: 0000950170-24-057453 · ownership.xml · nonDerivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,903 Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
Lenk Robert PDirector
|
GrantWarrants (Right to buy) · Derivative | 8,334 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0000950170-24-057451 · ownership.xml · derivative · entry 2 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,334 Underlying: Common Stock Warrants · 8,334 shares Expires not disclosed F1 · derivative.expiration_date: The expiration date for 4,167 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,167 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants. F2 · derivative.underlying: Half of the warrants are Series A warrants and the other half are Series B warrants. Read SEC document |
| May 08, 2024 Filed May 10, 2024 11:30 UTC |
Lenk Robert PDirector
|
PurchaseCommon Stock | 4,167 | $2.04 | $8,500.68 |
DisclosureSEC source: 0000950170-24-057451 · ownership.xml · nonDerivative · entry 1 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,327 Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:27 UTC |
Clowes HowardDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,250 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950170-24-020419 · ownership.xml · derivative · entry 1 Clowes Howard · CIK 0001806992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2034-02-22 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:26 UTC |
LaFrance Norman D.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 24,073 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950170-24-020418 · ownership.xml · derivative · entry 1 LaFrance Norman D. · CIK 0001397768 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,073 Underlying: Common Stock · 24,073 shares Expires 2034-02-22 F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:26 UTC |
HEDRICK MARC HDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 94,012 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950170-24-020417 · ownership.xml · derivative · entry 1 HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,012 Underlying: Common Stock · 94,012 shares Expires 2034-02-22 F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:25 UTC |
Sims Andrew John Hugh MacIntyreChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 18,933 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950170-24-020416 · ownership.xml · derivative · entry 1 Sims Andrew John Hugh MacIntyre · CIK 0001802687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,933 Underlying: Common Stock · 18,933 shares Expires 2034-02-22 F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:25 UTC |
Lenk Robert PDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,250 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950170-24-020415 · ownership.xml · derivative · entry 1 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2034-02-22 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:24 UTC |
van Es-Johansson AnDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,250 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950170-24-020414 · ownership.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2034-02-22 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:24 UTC |
Hawkins Richard JDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,250 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950170-24-020412 · ownership.xml · derivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2034-02-22 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:23 UTC |
Petersen GregDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,250 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950170-24-020411 · ownership.xml · derivative · entry 1 Petersen Greg · CIK 0001406815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2034-02-22 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| November 20, 2023 Filed Dec 15, 2023 22:09 UTC |
HEDRICK MARC HDirector · Chief Executive Officer
|
SaleCommon Stock | 2,068 | $1.96 | $4,052.66 |
DisclosureSEC source: 0001209191-23-058816 · doc4.xml · nonDerivative · entry 1 HEDRICK MARC H · CIK 0001203672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170 F1 · kind: The transactions reflect inadvertent trades made by the reporting person's custodian without authorization. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.9601 or $1.9768 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 12:00 UTC |
Lenk Robert PDirector
|
PurchaseCommon Stock | 1,000 | $1.95 | $1,950.00 |
DisclosureSEC source: 0001209191-23-055638 · doc4.xml · nonDerivative · entry 2 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,160 Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 12:00 UTC |
Lenk Robert PDirector
|
PurchaseCommon Stock | 1,000 | $1.77 | $1,770.00 |
DisclosureSEC source: 0001209191-23-055638 · doc4.xml · nonDerivative · entry 1 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,160 Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 12:00 UTC |
Lenk Robert PDirector
|
PurchaseCommon Stock | 4,000 | $1.43 | $5,720.00 |
DisclosureSEC source: 0001209191-23-055264 · doc4.xml · nonDerivative · entry 2 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,160 F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.44 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 10, 2023 Filed Nov 15, 2023 12:00 UTC |
Lenk Robert PDirector
|
PurchaseCommon Stock | 2,000 | $1.45 | $2,900.00 |
DisclosureSEC source: 0001209191-23-055264 · doc4.xml · nonDerivative · entry 1 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,160 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.47 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 12:00 UTC |
Lenk Robert PDirector
|
PurchaseCommon Stock | 4,199 | $1.59 | $6,676.41 |
DisclosureSEC source: 0001209191-23-054914 · doc4.xml · nonDerivative · entry 2 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,160 F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.59 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 12:00 UTC |
Lenk Robert PDirector
|
PurchaseCommon Stock | 5,000 | $1.65 | $8,250.00 |
DisclosureSEC source: 0001209191-23-054914 · doc4.xml · nonDerivative · entry 1 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,961 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.70 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2023 Filed Nov 8, 2023 12:00 UTC |
Lenk Robert PDirector
|
PurchaseCommon Stock | 6,000 | $1.64 | $9,840.00 |
DisclosureSEC source: 0001209191-23-054650 · doc4.xml · nonDerivative · entry 2 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,961 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.68 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 12:00 UTC |
Lenk Robert PDirector
|
PurchaseCommon Stock | 1,395 | $1.50 | $2,092.50 |
DisclosureSEC source: 0001209191-23-054650 · doc4.xml · nonDerivative · entry 1 Lenk Robert P · CIK 0001362635 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,961 Read SEC document |
| September 13, 2023 Filed Sep 15, 2023 11:00 UTC |
Clowes HowardDirector
|
PurchaseCommon Stock | 6,993 | $1.43 | $10,021.67 |
DisclosureSEC source: 0001209191-23-049535 · doc4.xml · nonDerivative · entry 1 Clowes Howard · CIK 0001806992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,693 Read SEC document |
| September 11, 2023 Filed Sep 12, 2023 11:00 UTC |
Petersen GregDirector
|
PurchaseCommon Stock | 20,000 | $1.70 | $34,062.00 |
DisclosureSEC source: 0001209191-23-049058 · doc4.xml · nonDerivative · entry 1 Petersen Greg · CIK 0001406815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,166 Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 11:00 UTC |
Clowes HowardDirector
|
PurchaseCommon Stock | 1,000 | $3.98 | $3,980.00 |
DisclosureSEC source: 0001209191-23-035267 · doc4.xml · nonDerivative · entry 1 Clowes Howard · CIK 0001806992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,700 Read SEC document |
| May 03, 2023 Filed May 4, 2023 11:00 UTC |
Clowes HowardDirector
|
PurchaseCommon Stock | 2,500 | $3.64 | $9,101.50 |
DisclosureSEC source: 0001209191-23-027213 · doc4.xml · nonDerivative · entry 1 Clowes Howard · CIK 0001806992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,700 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.